Financial results - CHAMOMILLA PHARM SRL

Financial Summary - Chamomilla Pharm Srl
Unique identification code: 24694660
Registration number: J13/3938/2008
Nace: 4773
Sales - Ron
327.302
Net Profit - Ron
6.368
Employees
6
Open Account
Company Chamomilla Pharm Srl with Fiscal Code 24694660 recorded a turnover of 2024 of 327.302, with a net profit of 6.368 and having an average number of employees of 6. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Chamomilla Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 263.210 289.352 329.825 335.468 306.521 308.961 299.852 329.819 324.926 327.302
Total Income - EUR 267.009 290.739 331.533 338.545 306.891 309.171 299.994 329.830 324.928 327.328
Total Expenses - EUR 271.362 301.002 344.263 351.770 349.294 300.617 279.398 310.152 316.746 316.639
Gross Profit/Loss - EUR -4.353 -10.263 -12.730 -13.225 -42.403 8.554 20.596 19.678 8.181 10.689
Net Profit/Loss - EUR -5.199 -10.263 -16.298 -16.611 -45.472 5.793 17.549 16.301 4.932 6.368
Employees 6 7 7 7 7 6 6 6 6 6
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 1.3%, from 324.926 euro in the year 2023, to 327.302 euro in 2024. The Net Profit increased by 1.463 euro, from 4.932 euro in 2023, to 6.368 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Chamomilla Pharm Srl

Rating financiar

Financial Rating -
CHAMOMILLA PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Chamomilla Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Chamomilla Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Chamomilla Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Chamomilla Pharm Srl - CUI 24694660

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 16.149 9.788 6.120 2.273 138 290 0 1.877 1.445 1.889
Current Assets 97.465 89.680 110.929 107.931 62.775 79.330 85.557 83.754 82.666 95.179
Inventories 55.499 62.561 67.856 60.930 30.432 39.822 49.991 48.399 50.335 55.412
Receivables 35.383 24.191 42.434 46.235 32.019 36.984 33.602 32.697 30.780 31.355
Cash 6.583 2.927 639 766 324 2.524 1.963 2.659 1.552 8.411
Shareholders Funds 45.065 34.919 18.030 1.088 -44.405 -37.770 -23.808 -17.686 -12.700 -6.262
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 69.203 64.819 99.284 109.376 107.574 117.641 109.610 104.243 97.735 117.814
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 95.179 euro in 2024 which includes Inventories of 55.412 euro, Receivables of 31.355 euro and cash availability of 8.411 euro.
The company's Equity was valued at -6.262 euro, while total Liabilities amounted to 117.814 euro. Equity increased by 6.367 euro, from -12.700 euro in 2023, to -6.262 in 2024.

Risk Reports Prices

Reviews - Chamomilla Pharm Srl

Comments - Chamomilla Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.